VRG100, isolated from an NRAS-mutant tumor, has a more undifferentiated/mesenchymal transcriptomic profile, as indicated by higher expression of genes as AXL, EGFR, ZEB1, TGFBI, SPOCK1, PVRL3, CTGF (Suppl. The gene discussed is CCN2; the disease is neoplasm.